WESTERN UNIVERSITY London researchers explore outcomes for patients with high potassium - Education News Canada

High levels of potassium in the blood, common in people on certain medications or with kidney disease, often come with no symptoms but can be deadly in severe cases. Because people with hyperkalemia, or high potassium, often "feel normal," their treating physicians must determine whether their condition can be safely managed outside the hospital or requires more urgent treatment in the emergency department. Researchers at Western University and London Health Sciences Centre Research Institute (LHSCRI) have shown that the risk of death was significantly lower among patients who were able to get to an emergency department within 24 hours of an abnormally high potassium reading.

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.